Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We pursue our goals using a radically innovative peptide-based patented technology platform.
G2B-002, our flagship product, is a new therapeutic approach for pediatric tumors such as Diffuse Intrinsic Pontine Glioma (DIPG). Our peptide-shuttle carries the effective therapeutic drug to the brain to fight this devastating condition. Our approach combines oncology, rare disease and pediatrics.